Soberlink - MAP Outcomes Study Protocol
| Status: | Terminated |
|---|---|
| Conditions: | Psychiatric |
| Therapuetic Areas: | Psychiatry / Psychology |
| Healthy: | No |
| Age Range: | 21 - 65 |
| Updated: | 5/17/2018 |
| Start Date: | August 22, 2017 |
| End Date: | April 27, 2018 |
The purpose of this study is to show the effectiveness of Soberlink's remote alcohol
monitoring system integrated with MAP's patient engagement platform (EHR) to monitor a sample
size of at-risk alcohol use disorder (AUD) population. Ultimately, this data is leveraged to
improve clinical outcomes and manage financial risk through facilitating early interventions
and other means of mitigating recidivism and costly treatment episodes from AUD population.
monitoring system integrated with MAP's patient engagement platform (EHR) to monitor a sample
size of at-risk alcohol use disorder (AUD) population. Ultimately, this data is leveraged to
improve clinical outcomes and manage financial risk through facilitating early interventions
and other means of mitigating recidivism and costly treatment episodes from AUD population.
The study will include 30 Clients with a primary or secondary diagnosis of alcohol use
disorder (AUD) and are enrolled in MAP's System where dedicated Case Managers are monitoring
the Client's relapse risk levels. Soberlink's remote alcohol system will provide data to
inform the Case Manager if the Client has relapsed or is at risk of relapsing through the use
of testing data compiled by the Soberlink System. Integrating Soberlink results into MAP's
EMR will allow Case Manager to make better clinical decisions and reduce costs by mitigating
the chances recidivism through early intervention. Clients will use the Soberlink Device for
a period of 90 days.
disorder (AUD) and are enrolled in MAP's System where dedicated Case Managers are monitoring
the Client's relapse risk levels. Soberlink's remote alcohol system will provide data to
inform the Case Manager if the Client has relapsed or is at risk of relapsing through the use
of testing data compiled by the Soberlink System. Integrating Soberlink results into MAP's
EMR will allow Case Manager to make better clinical decisions and reduce costs by mitigating
the chances recidivism through early intervention. Clients will use the Soberlink Device for
a period of 90 days.
Inclusion Criteria:
- Male or female subject between ages of 21-65 years old
- Subject is active in MAP's program with recovery support services
- Subject has received acute professional treatment in the last 120 days
- Primary or secondary diagnosis is Alcohol Use Disorder
- Subject willing to use Soberlink Device to provide BAC
- Subject is willing to discuss Soberlink test results with case manager
- Subject is willing to sign a Soberlink Client Agreement
- Subject is English speaking and reading
Exclusion Criteria:
- Alcohol Use Disorder is not a primary or secondary diagnosis
- Subject is currently taking anti-alcohol medications
- Subject will not be in the United States through duration of study
- Subject is unwilling to properly use the device
- Subject is non-English speaking and reading
- Subject is a child, adolescent, cognitively impaired, diagnosed with a mental
disorder, such as schizophrenia
We found this trial at
1
site
Click here to add this to my saved trials
